These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11193305)

  • 21. Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
    J Crit Care; 2011 Dec; 26(6):546-9. PubMed ID: 21273029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endotoxin adsorption by polymyxin B column or intraaortic balloon pumping use for severe septic cardiomyopathy.
    Nakamura K; Doi K; Inokuchi R; Fukuda T; Hiruma T; Ishii T; Nakajima S; Noiri E; Yahagi N
    Am J Emerg Med; 2013 May; 31(5):893.e1-3. PubMed ID: 23399331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
    Aoki H; Kodama M; Tani T; Hanasawa K
    Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of endotoxin scattering photometry for determining the efficacy of polymyxin B-immobilized fiber treatment in septic shock: report of a case.
    Sakamoto Y; Mashiko K; Obata T; Yokota H
    J Nippon Med Sch; 2010 Apr; 77(2):119-22. PubMed ID: 20453426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients with Septic Shock.
    Inoue S; Sakamoto Y; Koami H; Yamada C K; Nagashima F; Miike T; Iwamura T; Obata T
    J Nippon Med Sch; 2018; 85(1):39-46. PubMed ID: 29540645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The application of immobilized polymyxin B fiber in the treatment of septic shock associated with severe acute pancreatitis: report of two cases.
    Asanuma Y; Furuya T; Tanaka J; Sato T; Shibata S; Koyama K
    Surg Today; 1999; 29(11):1177-82. PubMed ID: 10552338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
    Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
    Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
    Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
    PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymyxin B-immobilized fiber hemoperfusion with low priming volume in an elderly septic shock patient with marked endotoxemia.
    Nakamura T; Kawagoe Y; Ueda Y; Koide H
    ASAIO J; 2005; 51(4):482-4. PubMed ID: 16156319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
    Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock.
    Nakamura T; Suzuki Y; Shimada N; Ebihara I; Shoji H; Koide H
    Blood Purif; 1998; 16(4):179-86. PubMed ID: 9736787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endotoxin adsorption: Direct hemoperfusion with the polymyxin B-immobilized fiber column (PMX).
    Shimizu T; Miyake T; Kitamura N; Tani M; Endo Y
    Transfus Apher Sci; 2017 Oct; 56(5):682-688. PubMed ID: 28923774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
    Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
    Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
    Nakamura T; Suzuki T; Kawagoe Y; Koide H
    ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature.
    Cruz DN; de Cal M; Piccinni P; Ronco C
    Contrib Nephrol; 2010; 167():77-82. PubMed ID: 20519901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
    Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
    Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
    Aoki H; Tani T; Hanasawa K; Shoji H; Kodama M
    Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):775-80. PubMed ID: 8377751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of endotoxin adsorption therapy (polymyxin B hemoperfusion) for methicillin-resistant Staphylococcus aureus toxic shock syndrome: a case report about five patients.
    Taniguchi T; Sato K; Kurita A; Noda T; Okajima M
    Minerva Anestesiol; 2013 Jul; 79(7):758-61. PubMed ID: 23635997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
    Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H
    J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.